Topic: childhood vaccines
Instead of launching their new combination pediatric shot now, Sanofi and Merck will spend this year building up supplies for a 2020 rollout.
Merck's RotaTeq won China approval in April and a launch is underway, but meanwhile, the company is reducing its shipments to low-income countries.
GlaxoSmithKline's moms against meningitis B are back on the air in TV ads promoting its Bexsero vaccine for back-to-college.
Sanofi Pasteur is urging parents to make sure teens get a second meningococcal booster vaccine in a new ad campaign timed for back-to-school.
Gavi's vaccine initiative will have saved 20 million lives and $350 billion in healthcare costs by 2020, a recent study found.
If Hilleman Labs is successful in scouting for a rotavirus vaccine partnership, India might see a new force added to its efforts to fight child and infant mortality caused by the deadly virus.
Right now, GlaxoSmithKline’s meningitis B vaccine, Bexsero, doesn’t have the key “universal use” endorsement the company wants from the CDC. So it’s spreading the word on its own.
Shortages of vaccines at clinics in China have predictably followed a move to eliminate middlemen from the sales chain.
Good news for GlaxoSmithKline, and those U.K. parents wanting to get their hands on its meningitis B vaccine, Bexsero: The wait is over.
Takeda has been given a $38 million grant from the Bill & Melinda Gates Foundation to help eradicate polio in developing countries.